Spencer Kimball, CNBC, March 23, 2022 Omicron’s more contagious subvariant, BA.2, has more than doubled in prevalence over the past two weeks in the U.S. and now represents more than 34% of Covid-19 infections that have undergone genetic sequencing, according …
As picture of COVID vaccine durability gets clearer, J&J makes a strong showing
Dana Varinsky, CNBC, March 19, 2022 When the early COVID vaccine trial results came out, an important indicator of success couldn’t yet be assessed: durability. Those initial studies were just three to four months — too short to determine how …
COVID cases are rising as omicron’s ‘stealth’ subvariant spreads around the world
Holly Ellyatt, CNBC, March 15, 2022 COVID cases are rising in Europe, with an increasing number being attributed to the prevalence of a “stealth” subvariant of the omicron strain. KEY POINTS Covid cases are rising in Europe with an increasing …
COVID booster effectiveness wanes after 4 months, but still provides protection against hospitalization, CDC study shows
Staff Reporter, CNBC, Feb. 11, 2022 An early look at the performance of Covid-19 booster shots during the recent omicron wave in the U.S. showed a decline in effectiveness against severe cases, though the shots still offered strong protection. KEY …
The latest COVID variant is 1.5 times more contagious than omicron and already circulating in almost half of U.S. states
Spencer Kimball, CNBC, Jan. 28, 2022 There are already dozens of cases across almost half of the U.S. of a new Covid subvariant that’s even more contagious than the already highly transmissible omicron variant. KEY POINTS The omicron subvariant, known …